Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

165
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
165
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

581
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
581
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.2K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing post-acquisition methods for Raman-based mineral identification of particles in yellow earth pigments.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Ontology-Enhanced Deep Learning for Mechanistic Prediction of Drug-Drug Interactions: A Clinically Interpretable Framework.

Journal of clinical pharmacology·2026
Same author

Enhancing Explainable AI Stability with Realistic Synthetic Data for Cardiovascular Risk Prediction.

Studies in health technology and informatics·2026
Same author

Mitigating the risk of invasive meningococcal disease in the umrah setting: Epidemiology, surveillance, and vaccination strategies.

Journal of infection and public health·2026
Same author

Knowledge graph embedding and alignment of incomplete electronic health records for critical care applications.

Journal of biomedical semantics·2026
Same author

Descriptive analysis of hypertension in Saudi Arabia: a national population health perspective (hypertension in Saudi Arabia).

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: Mar 9, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Drug-drug interaction discovery and demystification using Semantic Web technologies.

Adeeb Noor1, Abdullah Assiri2,3, Serkan Ayvaz4

  • 1Faculty of Computing and Information Technology, King Abdul Aziz University, Jeddah, KSA.

Journal of the American Medical Informatics Association : JAMIA
|December 30, 2016
PubMed
Summary

A new pharmacovigilance framework, the D3 system, infers mechanisms for known drug-drug interactions (DDIs) and predicts new ones. It achieved 85% recall and 61% precision, aiding drug safety and therapy adjustments.

Keywords:
Semantic Webdrug interactionspharmacologic actionspharmacovigilance

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.7K

Area of Science:

  • Pharmacovigilance
  • Drug Interaction Research
  • Computational Pharmacology

Background:

  • Drug-drug interactions (DDIs) pose significant risks to patient safety.
  • Understanding the mechanistic basis of DDIs is crucial for effective risk management.
  • Existing knowledge bases often lack comprehensive mechanistic explanations for DDIs.

Purpose of the Study:

  • To develop a novel pharmacovigilance inferential framework for elucidating DDI mechanisms.
  • To deduce potential novel DDIs based on integrated knowledge.
  • To create the drug-drug interactions discovery and demystification (D3) system.

Main Methods:

  • Constructed a mechanism-based DDI knowledge base integrating pharmacokinetic, pharmacodynamic, and pharmacogenetic data.
  • Developed a query-based framework utilizing 9 inference rules.
  • Applied the framework to asserted and potential DDIs.

Main Results:

  • The D3 system achieved an 85% recall rate for inferring mechanistic explanations of known DDIs.
  • Demonstrated a 61% precision rate in inferring or not inferring mechanisms for drug pairs.
  • Successfully confirmed interactions involving well-studied drugs.

Conclusions:

  • The D3 system enhances knowledge of known DDIs and deduces unknown DDIs.
  • Shows promise in identifying research pathways and aiding clinical decision-making.
  • Future work may involve ranking mechanisms and assessing DDI likelihood.